Athira Mukunda
De novo thyroid eye disease following COVID vaccination several years after radioiodine therapy
Mukunda, Athira; James, Jovito; Jacob, Rhea; Varughese, George I; Nayak, Ananth U
Authors
Jovito James
Rhea Jacob
George I Varughese
Ananth U Nayak
Abstract
Lesson: The delayed onset of thyroid eye disease is well recognised but less commonly perceived in routine clinical practice and this case report serves as a reminder for a high index of suspicion in at-risk patients.
Citation
Mukunda, A., James, J., Jacob, R., Varughese, G. I., & Nayak, A. U. (in press). De novo thyroid eye disease following COVID vaccination several years after radioiodine therapy. JRSM Open, 16(1), https://doi.org/10.1177/20542704241304220
| Journal Article Type | Article |
|---|---|
| Acceptance Date | Jan 9, 2025 |
| Online Publication Date | Jan 9, 2025 |
| Deposit Date | Jan 13, 2025 |
| Publicly Available Date | Jan 13, 2025 |
| Journal | JRSM Open |
| Print ISSN | 2054-2704 |
| Publisher | SAGE Publications |
| Peer Reviewed | Peer Reviewed |
| Volume | 16 |
| Issue | 1 |
| DOI | https://doi.org/10.1177/20542704241304220 |
| Keywords | thyroid eye disease, radioactive iodine, thyroid receptor antibodies, Grave's disease, COVID vaccination |
| Public URL | https://keele-repository.worktribe.com/output/1047008 |
| Publisher URL | https://journals.sagepub.com/doi/10.1177/20542704241304220 |
Files
De novo thyroid eye disease following COVID vaccination several years after radioiodine therapy
(455 Kb)
Archive
Licence
https://creativecommons.org/licenses/by-nc/4.0/
Publisher Licence URL
https://creativecommons.org/licenses/by-nc/4.0/
Copyright Statement
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
You might also like
Letter to the Editor: PCSK9 Inhibitors and Lipid Lowering: Viewpoint on Diabetic Retinopathy
(2024)
Journal Article